By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Provectus Biopharmaceuticals Inc. 

7327 Oak Ridge Highway Suite B

Knoxville  Tennessee  37931  U.S.A.
Phone: 866-594-5999 Fax:


Company News
Provectus Biopharmaceuticals Inc. Extends For Additional 60 Days Memorandum Of Understanding With Sinopharm-China State Institute Of Pharmaceutical Industry And Sinopharm A-Think Pharmaceutical Co., Ltd 5/18/2015 10:58:49 AM
Provectus Biopharmaceuticals Inc.’ Poster Presentation On PV-10 Clinical Data From Phase 1 Study For Cancers Of The Liver Scheduled For Thursday, July 2, 2015 At 17th World Congress On Gastrointestinal Cancer 5/15/2015 11:23:42 AM
Provectus Biopharmaceuticals Inc. And Sinopharm Facing MOU Deadline For Partnership 5/11/2015 4:01:17 PM
Provectus Biopharmaceuticals Inc. Updates Market On Business Developments 5/8/2015 8:28:30 AM
Provectus Biopharmaceuticals Inc. Reports First Quarter Financial Results 5/7/2015 12:47:34 PM
Provectus Biopharmaceuticals Inc.'s Novel Synthesis Patent Application Allowed By European Patent Office, Patent Issued By Japan 5/5/2015 10:51:43 AM
Provectus Biopharmaceuticals Inc.’ Abstract On Liver Cancer Accepted For Poster Presentation At European Society For Medical Oncology’s 17th World Congress On Gastrointestinal Cancer 4/30/2015 12:28:44 PM
Provectus Biopharmaceuticals Inc. Will Hold Its Quarterly Business Update Conference Call At 4 PM Eastern, Thursday, May 7, 2015 4/29/2015 12:22:29 PM
Provectus Biopharmaceuticals Inc. To Present At Asia Biotech Invest 2015 Conference Wednesday, May 20, 2015, Hong Kong 4/27/2015 11:29:21 AM
Pfizer (PFE) And Provectus Biopharmaceuticals Inc. Receive Patent Allowance For Use Of PV-10 In Combination With Systemic Immunotherapy Agents In Treatment Of Cancer 4/20/2015 11:24:51 AM